Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Virax Biolabs Group Limited (NASDAQ : VRAX ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
Quote
| Last: | $0.1676 |
|---|---|
| Change Percent: | 46.38% |
| Open: | $0.18185 |
| Close: | $0.1145 |
| High: | $0.1954 |
| Low: | $0.151 |
| Volume: | 237,575,363 |
| Last Trade Date Time: | 04/13/2026 12:45:59 pm |
Stock Data
| Market Cap: | $1,720,009 |
|---|---|
| Float: | 6,703,359 |
| Insiders Ownership: | N/A |
| Institutions: | 1 |
| Short Percent: | N/A |
| Industry: | Medical Diagnostics & Screening |
| Sector: | Healthcare |
| Website: | https://www.viraxbiolabs.com |
| Country: | GB |
| City: | Lanarkshire |
Recent News Releases
Subscribe to Our Newsletter
Message Board Posts
investorshub : glenn1919
investorshub : glenn1919
investorshub : INV4
investorshub : US Market News
**MWN-AI FAQ is based on asking OpenAI questions about Virax Biolabs Group Limited (NASDAQ: VRAX).
